Literature DB >> 26240979

Response to ten Broeke and Nielsen.

Noralane M Lindor1, McKinsey L Goodenberger2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26240979     DOI: 10.1038/gim.2015.90

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  3 in total

1.  Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.

Authors:  Sanne W ten Broeke; Richard M Brohet; Carli M Tops; Heleen M van der Klift; Mary E Velthuizen; Inge Bernstein; Gabriel Capellá Munar; Encarna Gomez Garcia; Nicoline Hoogerbrugge; Tom G W Letteboer; Fred H Menko; Annika Lindblom; Arjen R Mensenkamp; Pal Moller; Theo A van Os; Nils Rahner; Bert J W Redeker; Rolf H Sijmons; Liesbeth Spruijt; Manon Suerink; Yvonne J Vos; Anja Wagner; Frederik J Hes; Hans F Vasen; Maartje Nielsen; Juul T Wijnen
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

2.  A PMS2-specific colorectal surveillance guideline.

Authors:  Sanne W ten Broeke; Maartje Nielsen
Journal:  Genet Med       Date:  2015-08       Impact factor: 8.822

Review 3.  PMS2 monoallelic mutation carriers: the known unknown.

Authors:  McKinsey L Goodenberger; Brittany C Thomas; Douglas Riegert-Johnson; C Richard Boland; Sharon E Plon; Mark Clendenning; Aung Ko Win; Leigha Senter; Steven M Lipkin; Zsofia K Stadler; Finlay A Macrae; Henry T Lynch; Jeffrey N Weitzel; Albert de la Chapelle; Sapna Syngal; Patrick Lynch; Susan Parry; Mark A Jenkins; Steven Gallinger; Spring Holter; Melyssa Aronson; Polly A Newcomb; Terrilea Burnett; Loïc Le Marchand; Pavel Pichurin; Heather Hampel; Jonathan P Terdiman; Karen H Lu; Stephen Thibodeau; Noralane M Lindor
Journal:  Genet Med       Date:  2015-04-09       Impact factor: 8.822

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.